UK nanotechnology study shows promise for more effective cancer treatment compared to chemotherapy
Health News

UK nanotechnology study shows promise for more effective cancer treatment compared to chemotherapy


Dr. Peixuan Guo, one of the three top
nanobiotechnology experts in the world
A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. The study, published in Nano Today, was carried out in the laboratory of Peixuan Guo, the William S. Farish Endowed Chair in Nanobiotechnology at the UK Markey Cancer Center, in collaboration with Dr. Mark Evers, director of the UK Markey Cancer Center.

 "A major problem with cancer treatments is the ability to more directly and specifically deliver anti-cancer drugs to cancer metastases," Evers said. "Using the nanotechnology approach that Peixuan Guo and his group have devised may allow us to more effectively treat cancer metastasis with fewer side effects compared to current chemotherapy." To read more about the study, read the University of Kentucky press release here. To read study in Nano Today, go here.




- New Cancer Treatment For Late Stage Lung Cancer That Was Developed At Uk Is Approved For Clinical Trials
Researchers at the University of Kentucky have pioneered a new medical device for the treatment of late stage lung cancer, which has now been approved for clinical trials by the U.S. Food and Drug Administration at UK, auniversity news release says....

- Uk Cancer-center Director Urges Lawmakers To Raise Cigarette Tax And Pass A Statewide Smoking Ban To Reduce Cancer Deaths
The Markey Cancer Center at the University of Kentucky supports a statewide smoking ban and an increase in the state cigarette tax to significantly reduce cancer deaths in the state, the center's director told a legislative committee Sept. 3....

- Uk Researchers Work To Improve Identification Of Lung Cancer Patients Eligible For Participation In Clinical Trials For New Treatments
At the University of Kentucky, researchers are developing better strategies to identify lung cancer patients who could participate in clinical trials for new treatments. Lung cancer causes more deaths than any other kind of cancer worldwide, and Kentucky's...

- Study Finds 'the Link Between Cholesterol And Cancer Is Clear'
University of Rochester Medical Center scientists have verified a link between cholesterol and cancer with new genetic evidence, raising the possibility that cholesterol medications such as statin drugs could be used for cancer prevention or to augment...

- Markey Cancer Center At Uk Says Its Patients Have Higher Survival Rates Than Those Treated Elsewhere In Ky. And The Nation
"Patients at the University of Kentucky's Markey Cancer Center who have certain types of cancer have higher rates of survival than patients with the same cancers treated elsewhere in the state or even the nation according to new data released today,"...



Health News








.